Gallic acid-mitochondria targeting sequence-H3R9 induces mitochondria-targeted cytoprotection |
Bae, Yoonhee
(Department of Physiology, Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutic Center, Inje University College of Medicine)
Kim, Goo-Young (Department of Biology and Clinical Pharmacology, R&D Center, Samyang Biopharmaceuticals Corporation) Jessa, Flores (Department of Physiology, Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutic Center, Inje University College of Medicine) Ko, Kyung Soo (Department of Physiology, Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutic Center, Inje University College of Medicine) Han, Jin (Department of Physiology, Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutic Center, Inje University College of Medicine) |
1 | Bae Y, Joo C, Kim GY, Ko KS, Huh KM, Han J, Choi JS. Cationic oligopeptide-functionalized mitochondria targeting sequence show mitochondria targeting and anticancer activity. Macromol Res. 2019;27:1071-1080. DOI |
2 | Holder AL, Goth-Goldstein R, Lucas D, Koshland CP. Particleinduced artifacts in the MTT and LDH viability assays. Chem Res Toxicol. 2012;25:1885-1892. DOI |
3 | Soumya RS, Vineetha VP, Salin Raj P, Raghu KG. Beneficial properties of selenium incorporated guar gum nanoparticles against ischemia/reperfusion in cardiomyoblasts (H9c2). Metallomics. 2014;6:2134-2147. DOI |
4 | Sancho P, Galeano E, Nieto E, Delgado MD, Garcia-Perez AI. Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production. Leuk Res. 2007;31:969-978. DOI |
5 | von Heijne G. Mitochondrial targeting sequences may form amphiphilic helices. EMBO J. 1986;5:1335-1342. DOI |
6 | Yu GS, Han J, Ko KS, Choi JS. Cationic oligopeptide-conjugated mitochondria targeting sequence as a novel carrier system for mitochondria. Macromol Res . 2014;22:42-46. DOI |
7 | Schmidt N, Mishra A, Lai GH, Wong GC. Arginine-rich cell-penetrating peptides. FEBS Lett. 2010;584:1806-1813. DOI |
8 | Wolfram JA, Donahue JK. Gene therapy to treat cardiovascular disease. J Am Heart Assoc. 2013;2:e000119. DOI |
9 | Leo CH, Jelinic M, Ng HH, Parry LJ, Tare M. Recent developments in relaxin mimetics as therapeutics for cardiovascular diseases. Curr Opin Pharmacol. 2019;45:42-48. DOI |
10 | Rossignol P, Hernandez AF, Solomon SD, Zannad F. Heart failure drug treatment. Lancet. 2019;393:1034-1044. DOI |
11 | Dvir T, Bauer M, Schroeder A, Tsui JH, Anderson DG, Langer R, Liao R, Kohane DS. Nanoparticles targeting the infarcted heart. Nano Lett. 2011;11:4411-4414. DOI |
12 | Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 2011;9:55. DOI |
13 | Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. Int J Nanomedicine. 2014;9:467-483. DOI |
14 | Lin R, Zhang P, Cheetham AG, Walston J, Abadir P, Cui H. Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting. Bioconjug Chem. 2015;26:71-77. DOI |
15 | Cosentino K, Garcia-Saez AJ. Mitochondrial alterations in apoptosis. Chem Phys Lipids. 2014;181:62-75. DOI |
16 | Rin Jean S, Tulumello DV, Wisnovsky SP, Lei EK, Pereira MP, Kelley SO. Molecular vehicles for mitochondrial chemical biology and drug delivery. ACS Chem Biol. 2014;9:323-333. DOI |
17 | Weissig V, Boddapati SV, Jabr L, D'Souza GG. Mitochondria-specific nanotechnology. Nanomedicine (Lond). 2007;2:275-285. DOI |
18 | Klimpel A, Neundorf I. Bifunctional peptide hybrids targeting the matrix of mitochondria. J Control Release. 2018;291:147-156. DOI |
19 | Xie M, Hu B, Wang Y, Zeng X. Grafting of gallic acid onto chitosan enhances antioxidant activities and alters rheological properties of the copolymer. J Agric Food Chem. 2014;62:9128-9136. DOI |
20 | Perron NR, Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys. 2009;53:75-100. DOI |
21 | Bae Y, Jung MK, Lee S, Song SJ, Mun JY, Green ES, Han J, Ko KS, Choi JS. Dequalinium-based functional nanosomes show increased mitochondria targeting and anticancer effect. Eur J Pharm Biopharm. 2018;124:104-115. DOI |
22 | Tan KX, Pan S, Jeevanandam J, Danquah MK. Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers. Int J Pharm. 2019;558:413-425. DOI |
23 | AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279-290. DOI |
24 | Perelman A, Wachtel C, Cohen M, Haupt S, Shapiro H, Tzur A. JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis. 2012;3:e430. DOI |
25 | Yang Y, Xiang Y, Xu M. From red to green: the propidium iodidepermeable membrane of Shewanella decolorationis S12 is repairable. Sci Rep. 2015;5:18583. DOI |
26 | Xiang L, Xie G, Liu C, Zhou J, Chen J, Yu S, Li J, Pang X, Shi H, Liang H. Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation. Biochim Biophys Acta. 2013;1833:2996-3005. DOI |
27 | He H, Li DW, Yang LY, Fu L, Zhu XJ, Wong WK, Jiang FL, Liu Y. A novel bifunctional mitochondria-targeted anticancer agent with high selectivity for cancer cells. Sci Rep. 2015;5:13543. DOI |
28 | Madani F, Lindberg S, Langel U, Futaki S, Graslund A. Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys. 2011;2011:414729. |
29 | Bae Y, Green ES, Kim GY, Song SJ, Mun JY, Lee S, Park JI, Park JS, Ko KS, Han J, Choi JS. Dipeptide-functionalized polyamidoamine dendrimer-mediated apoptin gene delivery facilitates apoptosis of human primary glioma cells. Int J Pharm. 2016;515:186-200. DOI |
30 | Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C. Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater. 2019;10:4. DOI |